End-to-end program
Bring a target and plan a program with Achemol covering molecular design, screening, synthesis and experimental evaluation.
Scope a full programTarget-led drug discovery
Achemol’s in-house Vibedocking model helps design and screen small molecules. We take selected candidates into synthesis, in vitro assays and in vivo studies.
Research workflow
Commission all six stages or start with a compound, synthetic route or assay plan you already have.
Starting with a target name, identifier or research objective, we use Vibedocking to propose small-molecule structures for screening.
We screen proposed or supplied molecules in silico, compare predicted binding poses and prioritize candidates for testing.
We evaluate routes to selected compounds, identify starting materials and flag the steps that need feasibility work.
We prepare small batches of selected compounds and characterize them to the agreed research scope.
We select assays with your team and assess readouts such as activity or toxicity to inform the next research decision.
Together we select a preclinical model and readouts that fit the research question, then carry out the agreed study.
Collaboration
We work with pharmaceutical and academic teams to agree on responsibilities and deliverables at each stage.
Bring a target and plan a program with Achemol covering molecular design, screening, synthesis and experimental evaluation.
Scope a full programCommission one stage or several. Your team might handle synthesis while we screen candidates and carry out the follow-up studies.
Project inquiry
A target name or a short, non-confidential project summary is enough to begin.